Scientific Advisory Board

Leadership
Executive Committee
Admin Team
Scientific Advisory Board
The Scientific Advisory Board for N2CR serves as external consultants to provide feedback and insight on the research strategies, activities, progress and international standing of N2CR. It comprises of distinguished scientists with extensive expertise / experience as well as internationally recognised contributions to cancer research.

Chairperson

Professor Robert BRISTOW

MD, PhD, FRCPC FMedSci

Professor of Cancer Studies, Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, The University of Manchester  

Director, Manchester Cancer Research Centre 

Director, Cancer Research UK Major Centre 

Chief Academic Officer, The Christie NHS Foundation Trust 

SEE MORE

Member

Professor Alex A. ADJEI

MD, PhD

Chair, Taussig Cancer Institute, Cleveland Clinic, USA 

Member, Board of Scientific Counsellors, National Cancer Institute

Faculty coordinator, Developmental Therapeutics Faculty Group, European Society for Medical Oncology

Member, Gender Medicine Task Force, European Society for Medical Oncology

Member, AACR Task Force on Precision Combination Therapies

SEE MORE

Member

Professor Patrick J CASEY

PhD

Senior Vice Dean of Research, Duke-NUS Medical School

Professor, Cancer & Stem Cell Biology Programme, Duke-NUS Medical School

James B. Duke Professor of Pharmacology & Cancer Biology, Duke University

Professor of Biochemistry, Duke University Medical Centre

SEE MORE